Kevin Schuyler Adial Pharmaceuticals, Inc. (ADIL) insider trading activity

ADIL Quotes by TradingView

Kevin Schuyler is Director of ADIAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 700 shares of ADIL, which is worth approximately $735. The most recent transaction as insider was on Sep 29, 2023, when has been sold 700 shares (Common Stock) at a price of $2.74 per share, resulting in proceeds of $1,918. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 700
0% 3M change
Infinity% 12M change
Total Value Held $735

Kevin Schuyler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2023
BUY
Open market or private purchase
$1,918 $2.74 p/Share
700 Added 50.0%
700 Common Stock
Dec 23 2021
SELL
Bona fide gift
-
312,990 Reduced 100.0%
0 Common Stock

Also insider at

VEEE
Twin Vee PowerCats, Co. Consumer Cyclical
Director
FRZA
Forza X1, Inc. Consumer Cyclical
Director
KS

Kevin Schuyler

Director
Ft. Pierce, FL

Track Institutional and Insider Activities on ADIL

Follow ADIAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADIL shares.

Notify only if

Insider Trading

Get notified when an Adial Pharmaceuticals, Inc. insider buys or sells ADIL shares.

Notify only if

News

Receive news related to ADIAL PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADIL